| Name | Title | Contact Details |
|---|
Quidient brings 3D imagers, omni-directional lightfields and spatial processing together to deliver Intrinsic Imaging™.
Trapezoid® is an enterprise cloud cybersecurity company focused on the development and deployment of dynamic security and compliance postures, based on Intel Trusted Execution Technology (TXT).
Checkbox empowers business users to automate documents, workflows and assessments by rapidly building & developing apps through no code drag and drop.
Spot AI is the simplest way to move your video security to the cloud. It is one dashboard for all your cameras.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.